| Scorecard |
|---|
|
4 / 5 Stars
|
|
Lipper
5
4
5
5
3
|
|
Zacks Investment Research
5
(Strong Sell)
|
|
Standard & Poor's
5 / 5 Stars
|
|
TheStreet.com
A+
(Buy)
|
Risk
The fund's Value Line Risk Rank, a measure of volatility, is 2 on a scale of 1 to 5, with 1 being the least volatile and 5 the most.
Value Line 2013-03-12
Volatility Measurements
Updated 04.30.2013
| Standard Deviation | 10.92 |
| Mean | 1.41 |
| Sharpe Ratio | 1.54 |
| Bear Market Decile Rank | 1 |
Modern Portfolio Theory Statistics
Updated 04.30.2013
|
Standard Index MSCI World NR USD |
Best Fit Index Morningstar SEC/Healthcare TR USD |
|
|---|---|---|
| R-Squared | 69.79 | 96.99 |
| Beta | 0.55 | 0.85 |
| Alpha | 11.08 | 1.74 |
